Cost-cutting and preparing the balance sheet to be attractive for a sale to another company.

ll is quiet on all fronts - at least in Tax.

Sales reps are in Orlando this week at the yearly sales conference.

I am convinced, however, that there isn’t a plan to grow the business. All of the restructuring they are doing, in my opinion, is in the name of cost-cutting and preparing the balance sheet to be attractive for a sale to another company.

The language they have used doesn’t reflect growing the business and serving the most important asset: the customers and the trust they have placed in us over the years.

Reposted from @XnXft8J-6rsx .

Comment! It's anonymous!

4 replies (most recent on top)

What company would buy TR? Bloomberg? CCH?

Agility and process changes are a smokescreen to what’s really happening.

If you want the truth, follow the balance sheet, the stock price, and the shareholder meetings.

Need you be reminded that both life sciences and financial/risk have been spun off in recent years? Why did TR divest of them?

Most products are stagnant, so its hard to have a plan to grow the business.

You can still have agile because people are still going to baffle other people woth bs

I do not think so. There is more than cost cutting - process changes (agile) and other things that would not have been implemented if the only goal was short term gains.

Thread regarding Thomson Reuters layoffs

Cost-cutting and preparing the balance sheet to be attractive for a sale to another company.

4 replies (most recent on top)

Post a reply